CCMU
VTYX

Cheyne Capital Management (UK)’s Ventyx Biosciences VTYX Stock Holding History

Cheyne Capital Management (UK)’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,035
Closed -$657K – 53
2022
Q4 		$657K Buy
+20,035
New +$593K 1.15% 31

Other funds holding VTYX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cheyne Capital Management (UK)'s VTYX Position: Q1 2023 in Review

Cheyne Capital Management (UK) sold out of Ventyx Biosciences (VTYX) in Q1 2023, closing a stake of 20,035 shares — an estimated $657K sold.

Cheyne Capital Management (UK) first reported a position in VTYX in Q4 2022 and held it in 1 quarter. The position peaked at $657K in Q4 2022. 146 funds tracked by Wall St. Rank hold VTYX as of Q1 2023.

  • Cheyne Capital Management (UK) reported no remaining Ventyx Biosciences position as of Q1 2023 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 20,035 Ventyx Biosciences shares in Q1 2023, an estimated $657K.
  • Cheyne Capital Management (UK) first reported a position in Ventyx Biosciences in Q4 2022 and held it in 1 quarter.
  • Cheyne Capital Management (UK)'s Ventyx Biosciences position peaked at $657K in Q4 2022.
  • 146 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2023.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.